adalimumab

<!-- Name:DistributionId Value:8803426 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5500 -->…

<!-- Name:DistributionId Value:8801014 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5377 -->…

AVT02 as Simlandi™ is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure Alvotech (NASDAQ: ALVO) and Bioventure, a wholly owned subsidiary of GlobalOne Healthcare Holding LLC (“GHH”), the…

Alvotech (NASDAQ: ALVO) og Bioventure, dótturfyrirtæki GlobalOne Healthcare Holding LLC, heilbrigðissviðs YAS Holding LLC, tilkynntu í dag að lyfja- og matvælaeftirlit Sádi-Arabíu (SFDA) hafi veitt leyfi til framleiðslu og sölu á AVT02,…

Hukyndra® (adalimumab) launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe Follows initial introduction of Hukyndra in…

SHANGHAI, China, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and…

PALO ALTO, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- A correction has been issued for the release disseminated under the same headline on Thursday, November 15th by 180 Life Sciences Corp. An embedded link has been added to the 5th…

Long term follow-up data from British Association of Dermatologics and Immunomodulators Register (BADBIR) shows safety and effectiveness of SB5 in patients with psoriasis who have started or transitioned from reference adalimumab INCHEON,…

— Multiple near-term anticipated product launches and development of innovative immuno-oncology pipeline position Coherus for long-term growth – — Introducing 2026 revenue target of $1.2 billion in annual net sales from Coherus' …

Pune, India, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The global “adalimumab biosimilar market” is poised to experience a steady growth period owing to the rising incidence of arthritis. According to the World Health Organization (WHO),…